EDWARDS LARRY TODD (Chief Commercial Officer) received a stock award from ORUKA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/25/2026ACC: 0000907654-26-000084
Officer· Chief Commercial Officer
Since Aug 2026
+120K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
120K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
—
Trade value
—
% of position
New position
8/24/2026
0.00→100K
Total
Net shares
+100K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/24/2026 | A · Award | +100K | — | — | New position | 0.00 | 100K |
| Total | +100K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
20K shares
Shares
+20K
Strike price
102.42
Held after
20K
Exercisable
—
8/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock20K shares | 8/24/2026 | A · Award | +20K | 102.42 | — | 20K |